Skip to main content
Equibles
PROF logo

PROF · Profound Medical Corp.

Track PROF — free

Use PROF with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about PROF

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$6.79 +0.14 (+2.11%) At close · Aug 21
Market Cap
$248.06M
Shares
36.53M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$6.79 Open$6.75 Day$6.52–6.85 52W close$3.87–8.65 Avg vol 30d118K Short int1.8M · 4.9% float · 14.7d Short vol19% Last earningsAug 6, 2026 DataJan 2020–Aug 2026 Filing10-Q · Aug 6

Up next

Next earnings call
Oct 22, 2026 Est · unconfirmed · in 9 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 6, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Sell
      SellHoldBuy
      Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Excellent Quant / Vol Very High
      Market backdrop VIX 15.1 · calm Equity put/call 0.51
      Technical
      price trend
      Sell
      50 / 200-day cross No cross
      Price vs 200-day avg −1%
      below
      Price vs 50-day avg −3%
      below
      RSI (14) 45
      neutral
      MACD trend Negative
      52-week position 61%
      mid-range
      Momentum
      relative strength
      Very Weak
      1-month return −6%
      trailing
      6-month return −9%
      trailing
      YTD return −14%
      this year
      Relative strength −21%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $7 › 200d $7 — 50d above 200d
      Institutional flow Flat
      0% holders QoQ · +6 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      4.94% of float · ▼ -2.6% MoM · 14.7 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      58 holders — mid 3-yr range
      Squeeze score 70
      elevated · 0–100
      Fundamentals
      Excellent
      Revenue growth +51%
      Y/Y
      Gross margin 71%
      expanding
      EPS growth +26%
      Y/Y
      Free cash flow $-38.4M
      Balance sheet $53.5M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 70%
      annualized · 1-yr
      Max drawdown −42%
      past year
      ATR 6.6%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed Aug 6, 2026
      Total revenue · full-year 2026 Initiated $25M
      prior FY $16.1M midpoint +55.3% Y/Y
      Prior guidance period ended · from the 8-K filed Oct 7, 2025
      Total revenues · the third quarter of 2025 $5.2M – $5.3M
      Gross margin · the third quarter of 2025 72%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Sell
      1 · 5 · 0
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −1% Neutral
      Price vs 50-day avg
      −3% Neutral
      RSI (14)
      45 Neutral
      MACD trend
      Negative Bearish
      52-week position
      61% Neutral
      Market signals — smart money & positioning
      Bullish · 1 of 6
      Trend (MA cross) No cross
      50d $7 › 200d $7 — 50d above 200d
      Institutional flow Flat
      0% holders QoQ · +6 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      4.94% of float · ▼ -2.6% MoM · 14.7 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      58 holders — mid 3-yr range
      Price context
      position in its 52-week range
      Range low $4 Now $7 · 61% Range high $9
      vs 200-day avg -1% vs 50-day avg -3%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Payer coverage expanded 18.3M Q2-2026 —
      covered lives added in the first quarter 8.5M Q1-2026 —
      TULSA INDEX20 # TULSA Sites 20 Q1-2026 —
      TULSA INDEX20 Average Procedures Annualized 45.2 Q1-2026 —
      TULSA INDEX20 Average Procedures/Quarter 11.3 Q1-2026 —
      TULSA INDEX20 Year-Over-Year Growth 59% Q1-2026 —
      TULSA-PRO installed base 80 end of Q1-2026 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Medical Devices — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      PROF
      Profound Medical Corp.
      this stock
      		$248.06M -13.7% +50.7% — 4.9%
      ABT
      Abbott Laboratories
      		 $203.17B -6.9% +5.7% 32.7 1.3%
      SYK
      Stryker Corp
      		 $126.37B -6.3% +11.2% 34.1 2.2%
      MDT
      Medtronic plc
      		 $119.47B -2.8% +8.4% 25.0 1.4%
      BSX
      Boston Scientific Corp
      		 $73.00B -47.2% +12.5% 20.4 1.5%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Reducing
      Holders
      58
      % held
      44.3%
      Net QoQ
      -251.5K sh
      Top holder
      FIL Ltd
      Held Float
      View
      Held by Funds
      Fund positions
      9
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      1.8M
      Days to cover
      14.7d
      Change
      -47.4K sh
      View
      Short Volume
      Short vol %
      19%
      As of
      Aug 21, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      103
      Value
      $746
      As of
      Jul 30, 2026
      View
      Off-Exchange
      Off-exchange %
      47.8%
      Week of
      Jul 13, 2026
      Off-exch Lit
      View
      Smart Money
      Congressional Trades Buy
      Member
      Tom Malinowski
      Amount
      $1.0K–$15.0K
      Traded
      Jul 21, 2020
      View
      Financials
      Financials
      Revenue (FY)
      $16.1M
      Net income (FY)
      $-42.6M
      EPS diluted
      $1.41
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 17, 2026
      This year
      28
      View
      Proposed Sales
      Value
      $105.5K
      Shares
      13.0K
      Filed
      Nov 12, 2024
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 6, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      PROF +2.4% -6.5% -9.0% -8.0% -13.7%
      SPY -1.4% +3.6% +11.6% +2.5% +12.3%
      vs SPY +3.8% -10.1% -20.5% -10.5% -26.0%
      Key facts CIK 1628808 CUSIP 74319B502 13F (30d) 54 filings 54 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)